RELATED CONTENT
NEWS
- NICE drug wars: Tarceva vs Iressa, Revlimid vs IFN alpha, Botox vs SoC, and others
- NICE decision puts down a marker for drug development
- Astellas mulls darexaban alliances as pipeline moves forward
- AVEO's unconvincing Phase II ficlatuzumab data point to need for further studies
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

